Iboga: the root that shows you

Les plantes-maîtresses, approchées par dévotion — ce qu'elles enseignent quand on les laisse être ce qu'elles sont.

tagline · path

Les plantes-maîtresses, approchées par dévotion — ce qu'elles enseignent quand on les laisse être ce qu'elles sont.

— Les plantes-maîtresses, approchées par dévotion — ce qu'elles enseignent quand on les laisse être ce qu'elles sont.

Iboga: the root that shows you

Tabernanthe iboga, the sacred root of the Babongo and the Gabonese Bwiti — to meet it through devotion, not through consumption.

— It does not show you God. It shows you what you refuse to look at. The nuance is everything. —

§0 — A fissure to begin with

We have all seen, on YouTube, Westerners coming out of an ibogaine course saying "I saw God." What the video does not show: about one person in three hundred does not come out of that meeting alive when it is poorly held (Alper et al., Treatment-related mortality of ibogaine therapy: a review of fatalities, 2012). The Babongo, whose ancestors were the first to eat the root perhaps seven thousand years ago, do not say "I saw God." They say: "it showed me what I needed to see."

Here is the fissure, laid out plainly:

Iboga does not manufacture visions. It gives you back your sight.

It is a distinction that changes the posture. The word vision is a trap; it evokes spectacle. Among the Gabonese Bwiti, what one meets carries another name — miyongo, or masango, or simply the road. You do not go to watch a cosmic film. You go to walk back up your own. You go, slowly, over the duration of the initiation — which can last between twenty-four and seventy-two hours — to rejoin the ancestors who wait at the other end. What you meet is not outside. What you meet is what you have always carried, and that the root brings to light.

This article is not a use guide. INFUSE does not sell iboga, will not tell you how to find it, will not promote a protocol. This article is an offering of precision. An essay to say, in English, what this plant truly is — botanically, chemically, culturally, ethically. To give the root back the dignity that seven thousand years of Gabonese keeping have conferred on it. To give the Babongo, the Mitsogo, the Apindji, the Fang back what they have transmitted — a living knowledge, and not a feel-good product.

To drink iboga without having read a book on the Bwiti is exactly what modernity has learned to do: take the molecule, throw away the context. You can do it. Many have done it. Some gained a fresh start from it. Others lost their lives to it. None truly met the plant.

— If you enter the forest without greeting the trees, it is not the trees who will be in the wrong. —

I. Opening in honour

Before any other word, to name.

Tabernanthe iboga is a shrub that grows in the humid undergrowth of Gabon, southern Cameroon, the Republic of the Congo (Brazzaville) and the western Democratic Republic of the Congo. The Apocynaceae family — the family of the Madagascar periwinkle, the oleander, the frangipani. A small, discreet shrub, hardly more than two metres in the wild, that can reach ten metres in protected cultivation. Oval leaves, pinkish-white flowers grouped in terminal clusters, oval orange fruits ripening through all the shades of the setting sun. And, below the ground — there is the sacred — a yellow-orange taproot, fleshy, whose bark, dried then grated, concentrates the plant's pharmacopoeia.

The peoples who made a religion of it are not an indistinct "African" mass. They must be named one by one.

The Babongo — often called Bongo, sometimes assimilated to the Pygmies in the French-language anthropological literature — live in the forests of central and southern Gabon. They are, according to several Bwiti oral sources, the first to have "met" iboga. The tradition tells that a Babongo hunter saw a porcupine or a mandrill digging the earth to chew the root, then entering a state where fear vanished. The hunter did the same. It is in that meeting — the animal who teaches the human — that the Bwiti lineage situates its origin.

The Mitsogo (or Tsogo), a Bantu people of western Gabon, are today regarded by James W. Fernandez (Bwiti: An Ethnography of the Religious Imagination in Africa, Princeton, 1982) as the principal keepers of the initiatory branch of the Bwiti — the one that trains the nima na kombo, the "grandmothers of the rope," those guides who hold the road during the initiation. The Mitsogo have a formula for iboga: sacred wood, eboka, the one who shows.

The Apindji and the Massango, neighbouring peoples, largely share this tradition.

The Fang, a more northern, more numerous Bantu people, massively adopted the Bwiti at the start of the 20th century, creating a syncretic variant sometimes called Bwiti Fang or Bwiti Disumba — which integrates Christian elements (Mary, Jesus, the idea of a sacred book) into the pre-existing initiatory structure. This adoption was both an act of cultural resistance against French colonisation and a major religious event in the modern history of Gabon.

The Nkomi and the Punu complete the map.

None of these peoples "owns" iboga. They received it. They named it. They transmit it. This distinction is essential for anyone who would, from the West, speak of it honestly: the plant is no one's property, but the knowing-how-to-live-with-it belongs to a living, precise, situated lineage, transmitted by initiation and not by book.

"Iboga is described as a 'generic ancestor' that can carry the initiate to the realm of the dead." — Richard Evans Schultes & Albert Hofmann, Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers (Healing Arts Press, 1992, pp. 112–115) — INFUSE reading — Schultes, the American dean of 20th-century ethnobotany, and Hofmann, the discoverer of LSD, set down in five words what seven thousand years of Gabonese keeping carry: the root is not a molecule, it is an ancestor. The word generic does not devalue — it means: belonging to the lineage, received through the lineage. To speak to it as to a product is a grammatical as much as an ethical contradiction.

INFUSE writes this article from an honest place: with no initiate’s authority, without having taken part in a Bwiti ceremony, without having eaten iboga. This article is the fruit of careful reading — cross-checked, verified — not of a lineage. We say so from the outset because it is the minimum ethic: who speaks, from where, with what authority.

That is why INFUSE will never sell iboga. It is not out of legal caution (the law varies). It is not out of fear of the risk (the risk exists and can be managed). It is because to sell the root is to betray the grammar of its meeting. This point — which is neither a warning nor an excuse — will be developed in §VI. For now, the plant itself must be described.

II. What it is botanically

The Apocynaceae family

Tabernanthe iboga (Henri Baillon, 1889, who described the species from samples brought back from Gabon) belongs to the great Apocynaceae family. This family — around five thousand species, including the periwinkle, the oleander, the frangipani, the quebracho — is known for producing indole alkaloids of great pharmacological complexity. Vincristine and vinblastine, major anticancer agents of the 20th century, come from Catharanthus roseus, the Madagascar periwinkle. The Rauvolfia provide reserpine, the first effective Western molecule against hypertension. This family, in short, is not neutral: it speaks in heavy alkaloids, with a narrow therapeutic margin. Iboga is one of its summits.

The shrub usually measures one to two metres in its natural undergrowth — it can reach ten metres in exposed cultivation, which surprises the first time one sees it grown in full light. Evergreen foliage, dark green. White-to-pink flowers, fragrant, grouped in terminal cymes. Oval fruits, orange at ripening, containing black seeds.

The taproot — the sacred part — can reach sixty centimetres deep in the forest earth. It is the root that is harvested. It is in the bark of this root, more precisely, that the alkaloids concentrate. The whole dried root, grated into shavings or powder, is the base material of the Bwiti initiation.

Habitat and cultivation

Iboga loves the dense shade of the equatorial undergrowth, the constant humidity (two thousand to three thousand millimetres of rain a year), the acid soil rich in forest humus, and stable temperatures (twenty to thirty degrees Celsius, never below fifteen). It grows spontaneously from Gabon to the Lower Congo, by way of southern Cameroon. In the 20th century, several attempts to cultivate it outside equatorial Africa were made — Costa Rica, Hawai'i, certain specialised European greenhouses — with varying success. The plant grows, but slowly: it takes five to seven years before a root becomes charged enough with alkaloids to have a ceremonial value. In the wild, some sacred roots used by the nima na kombo are several decades old.

This is one of the crucial points for understanding the current conservation stakes: world demand for ibogaine far exceeds the natural capacity for regeneration. A five-to-seven-year-old plant is not an asparagus harvested every year. The industrial extraction for the Western pharmacopoeia of opioid withdrawal directly threatens the wild Gabonese resource — to the point that CITES (the Convention on International Trade in Endangered Species of Wild Fauna and Flora) listed Tabernanthe iboga in Appendix II in 2022, framing its international trade. Gabon, for its part, legislated as early as Law 22/94 to limit the export and to recognise iboga as national cultural heritage.

Related species and confusions

The Tabernanthe genus contains several species. Tabernanthe orientalis (East Africa) and Tabernanthe pubescens are sometimes confused with T. iboga on the grey market of the internet, but their alkaloid profile is very different. An "iboga" root bought outside Gabon, with no botanical certification, can be something else entirely. This confusion has killed — literally — several Westerners who thought they were buying Bwiti root and received inactive adjacent plants, or worse, powders adulterated with synthetic alkaloids.

Sensory — how the root tastes

The dried root bark, chewed, has a deeply bitter, earthy taste, a little metallic at the back of the mouth. Several Bwiti sources speak of a "taste of burnt earth" — it is precise. The palate resists, the saliva rises, the mouth goes dry. There is no pleasantness; there is only the head-on meeting with the root. Bwiti initiates tell that this taste is itself the first gate — it must be crossed, held, not spat out. For the massive doses of the initiation, the shavings are chewed by the mouthful, then swallowed with water or a little honey. The process, slow, methodical, takes hours.

"Each visionary plant has its own 'signature' — a distinct phenomenological character that shapes the content, texture, and moral quality of the encounter. Morning glory speaks with prophetic clarity; peyote teaches through song and prayer; ayahuasca operates through visual narrative and purging; iboga confronts with ancestral memory." — Dale Pendell, Pharmako-Gnosis: Plant Teachers and the Poison Path (Mercury House, 2005 / North Atlantic Books, 2010) — INFUSE reading — Pendell, who spent his life listening to what plants have to say, gives here a distinction of rare precision. Iboga confronts with ancestral memory. Not through dream, not through inner dance, not through widened perception. Through memory. You walk back up, slowly, all you have done, lived, fled. You meet your ancestors — in the literal sense among the Bwiti, in the psychic sense for those not initiated. And they tell you, without complacency, what they have seen of you. It is in this that the root is the one who shows.

III. Chemistry and neurobiology

Iboga is, pharmacologically, one of the most complex plants known. It speaks simultaneously to at least five families of brain receptors, in an orchestration that modern science is only just beginning to describe.

The principal alkaloids

The root bark contains around six per cent alkaloids by dry weight, the overwhelming majority of which are ibogane-type indole alkaloids. More than seventy different molecules have been identified (Mash et al., Ibogaine: complex pharmacokinetics, concerns for safety, Annals of the New York Academy of Sciences, 2000). Five dominate:

Ibogaine (C₁₉H₂₆N₂O) — discovered in 1901 by Dybowski and Landrin (French chemists), isolated in 1957 by J. Büchi. It is the major alkaloid, about eighty per cent of the alkaloid mass. Plasma half-life: seven to twelve hours.

Noribogaine (C₁₈H₂₄N₂O) — the principal metabolite of ibogaine in the liver (by the cytochrome CYP2D6). A longer plasma half-life: twenty-four to sixty hours. It is noribogaine, and not ibogaine itself, that seems responsible for the prolonged anti-addictive effect. Glue et al. (Ibogaine and noribogaine: pharmacokinetics and effects on opioid withdrawal, British Journal of Clinical Pharmacology, 2015) provide its precise pharmacokinetic mapping.

Tabernanthine, ibogamine, ibogalline — minor alkaloids, little studied in isolation, probably contributing to the "cortège" effect of the whole plant, what ethnobotanists call the entourage effect.

The mechanisms — at least five families of receptors

The pharmacology of ibogaine is, still today, partly untangled. Here are the identified targets:

NMDA antagonist — ibogaine blocks the N-methyl-D-aspartate receptors of glutamate, which partly explains its action on memory (the NMDA receptors play a central role in memory consolidation) and on perceptual dissociation.

Sigma-2 (σ₂) — a strong affinity. The sigma receptors are involved in neuronal plasticity and dopaminergic regulation. It is probably by this route that ibogaine "resets" certain reward circuits.

Kappa-opioid agonist — which explains why it can block the opioid withdrawal syndrome, by occupying the receptors that morphine or heroin occupied.

Mu-opioid antagonist — paradoxically, it also blocks the euphoriant effect of opiates, which explains the anti-relapse effect.

Sodium-channel blocker (hERG) — it is this mechanism that makes ibogaine cardiotoxic: by blocking the hERG channels in the cardiomyocytes, it can lengthen the QT interval and trigger a torsades de pointes-type arrhythmia, potentially fatal (Koenig & Hilber, The anti-addiction drug ibogaine and the heart: a delicate relation, Current Drug Abuse Reviews, 2015).

The cardiotoxicity — a fact, not a fright

It must be said calmly, without making it the subject of the article: about one person in three hundred dies of a poorly held initiatory dose of ibogaine (Alper et al., 2012). The cause of death is almost always cardiac — arrhythmia, ventricular fibrillation, arrest under prolonged QT. The known risk factors:

a genetic predisposition to long QT;

dehydration, electrolyte imbalance (low potassium);

the absence of cardiac monitoring during the first twelve to twenty-four hours post-ingestion;

co-medication with other cardioactive molecules (methadone, tricyclic antidepressants, certain antibiotics);

use in opioid-dependent people — the abrupt pharmacological transition worsens the cardiac fragility.

The clinics that practise ibogaine with continuous cardio-monitoring, in a strict medical frame, bring this mortality rate below one in ten thousand (Mash et al., Ibogaine therapy: a 'vast, uncharted territory', 2018). The risk is real; it can be managed; it does not disappear. That is what must be held simultaneously.

Among the Bwiti, the initiation is done with a nima na kombo present continuously, who watches the pulse, the breath, the skin, the colouring. The lineage has its own warning signs, transmitted over generations. Mortality in traditional Bwiti initiations is poorly documented — some oral sources speak of one case every five to ten years, in a lineage that initiates dozens of people a year. The difference is not only medical: it is ritual, cosmological, communal. When someone dies under iboga among the Bwiti, it is not a medical failure, it is that the ancestor has called them back. This way of holding death within the sacred is not exportable. It is one of the reasons Western clinical protocols cannot reproduce the Bwiti initiation: they do not carry the same grammar.

"The poison path is not self-sufficient. It requires a 'baseline bioassay' — sustained contemplative practice that provides a stable reference point. Without ground state training, the visions become untethered and the poisoner is consumed by the poison." — Dale Pendell, Pharmako-Gnosis (Mercury House, 2005) — INFUSE reading — It is the fundamental ethical warning Pendell sets down, after a life of writing on the pharmakon. Without a ground state — without prior contemplative practice, without community, without lineage — iboga does not show you: it devours you. The cardiac deaths are a visible part of the risk. The other part — psychic — is silent but real: post-course decompensations, prolonged dissociative states, a stupor that lasts months. Iboga does not forgive the Western arrogance that thinks it can take the molecule while leaving the cosmology to the Gabonese.

IV. The Bwiti — a living religion of Gabon

It is here that the article slows. It is the central part.

Origins — a transmission by lineage

The Bwiti, as it exists today, comes from a historical meeting between several lineages: the original Babongo practice (which is lost in historical depth — seven thousand years according to some archaeological estimates), its adoption by the Mitsogo, the Apindji, the Massango (probably in the 19th century, but with older roots), then its massive spread among the Fang at the start of the 20th century. This last step — the Fang adoption — was both a religious event and an act of cultural resistance against French colonisation and Christian evangelisation.

James W. Fernandez, an American anthropologist who lived twenty years with the Fang Bwiti of Gabon, and whose Bwiti: An Ethnography of the Religious Imagination in Africa (Princeton University Press, 1982) remains the reference work in English, distinguishes two great contemporary branches:

The Mitsogo Bwiti (or Disumba) — closer to the pre-colonial initiatory forms, centred on the meeting with the ancestors, the idea of the cosmic tree (often identified with iboga itself), the nocturnal circular dances around the ritual fire.

The Fang Bwiti (or Mwiri / Buiti) — syncretic, integrating Mary, Jesus, the idea of a sacred book (sometimes the Bible itself re-read), while keeping the initiatory structure of the eboka. This branch is today the most publicly visible.

The initiation — how it really happens

A Bwiti initiation typically lasts between twenty-four and seventy-two hours. It takes place in a mbandja, the Bwiti temple — often an open space with a central pole, sometimes carved, that symbolises the cosmic tree. The ritual fire (ngoze) burns the whole duration of the initiation. The ngombi, the sacred eight-stringed harp, plays continuously; the Bwiti songs, in Mitsogo or in Fang, cross the night.

The initiate ingests the root in progressive doses. The estimates vary by lineage: between one hundred and three hundred grams of dried root over the duration of the initiation, that is the equivalent of six to twelve milligrams of ibogaine per kilo of body weight, or ten to thirty times the dose that would produce a mild psychoactive effect. It is a threshold dose, in the cosmological sense and in the etymological sense: one crosses over.

The effects unfold in three approximate phases, as the ethnographic literature describes them:

The phase of psychophysical effects (the first hours) — an intense nauseous rise, vomiting (which the Bwiti consider a necessary purification — the body rejects what must be rejected), heightened auditory perception, a sensation of inner vibration, amplified sounds, a drop in motor coordination. The initiate must remain lying down.

The visionary phase (the sixth to the eighteenth hour) — eyes closed, almost total stillness, a state close to waking REM sleep. It is in this phase that the meetings with the ancestors take place, the voyage on the road, the confrontations with the initiate's own life. No outer movement. Everything happens in memory and in inner perception.

The integration phase (the eighteenth to the seventy-second hour) — a gradual return, a clear and strange lucidity, a feeling of "coming out of a long voyage." It is in this phase that the Bwiti songs, the ngombi, the presence of the community weave the lived experience into the social and cosmological fabric of the people.

The nima na kombo — the one who holds the rope — remains present continuously. The word means literally "grandmother/parent of the rope" (kombo naming both the umbilical cord and the initiatory rope). This person is not a therapist, nor a doctor, nor a shaman in the Western sense. They are a ferryman — someone who has made the passage before, who knows the traps of the road, and who maintains the ritual link while the initiate travels through their own memory.

"The bambzie or banzie (initiated members of the Bwiti cult) relate visions of traveling 'a long, multicolored road or over many rivers' to meet ancestors who then take them to the great gods." — Richard Evans Schultes & Albert Hofmann, Plants of the Gods (Healing Arts Press, 1992, p. 113) — INFUSE reading — The multicoloured road is one of the key images of the Bwiti. It returns in independent accounts, across generations, across the two great branches Mitsogo and Fang. It is one of those phenomenological structures that resist a purely neuro-pharmacological explanation: why the same image, over decades, across neighbouring cultures? The Bwiti do not put the question that way. For them, it is the road — it exists, it waits, one takes it.

The songs — the ngombi and the voice

The ngombi, the sacred eight-stringed harp, is probably the central instrument of the Bwiti. Its sound-box is often carved with a human face — it is the ancestor-instrument, which sings with the community. The Bwiti songs, whether in Mitsogo, in Fang, in Apindji, follow precise cycles: kombo ya nga (the opening song), the initiation songs, the songs of return. No song is random. Each has a ritual function — to accompany the nauseous phase, to guide the visionary phase, to accompany the return.

What Western science discovered in the 2010s — the critical importance of the "auditory setting" in any psychedelic experience (Carhart-Harris, Imperial College London, The therapeutic potential of psilocybin, Lancet Psychiatry, 2016) — the Bwiti have practised for centuries. Without ngombi, without songs, without a held rhythm, there is no possible initiation. Pharmacology without the music is, in the Bwiti lineage, literally incomplete.

Iboga, Bwiti, and colonial resistance

This point must be named. At the moment when the French colonial administration tried, in the 1920s–1950s, to ban or criminalise the Bwiti practices, iboga became a symbol of cultural resistance. To adopt the Bwiti, or to refuse to abandon it, became a political act. This dimension is not incidental: it explains why, today, Gabon legally protects the plant (Law 22/94, the 2000 national-cultural-heritage classification), why the Gabonese National Ethics Committee is strict on the export of root, why several contemporary Bwiti spokespeople — including Yann Guignon, founder of the Blessings of the Forest association, and Tatayo (Atome Ribenga), a French nima na kombo settled in Gabon — have been asking for twenty years that the West stop extracting the root while giving nothing in return.

"You cannot just take the molecule and leave behind the cosmology that holds the molecule safely. This is not an opinion. This is what we are watching kill people right now." — Yann Guignon, Blessings of the Forest (an international association for the safeguarding of iboga and the Bwiti), interview cited by VICE / Motherboard, 2019 — INFUSE reading — Guignon, who is not Gabonese by origin but who was initiated over the long term and recognised by the lineage, gives the sentence to cite at the close of any discussion of Western therapeutic iboga. You cannot take the molecule and leave the cosmology. Not for mystical reasons. For measurable ones: without the lineage, the mortality rate explodes, addictive relapses are frequent, the experience empties of its meaning. The Western separation between pharmacology and ritual is, in the case of iboga, a deadly epistemological error.

V. Iboga and addiction medicine — the story of Howard Lotsof and its aftermath

This section is necessary because it is through this door — addiction medicine — that iboga entered the Western consciousness of the 20th century. It must be told, without complacency or disparagement.

Howard Lotsof, 1962

Howard Lotsof is a young American of nineteen, a heroin addict for several years, living in New York. In 1962, a chemist friend offers him a new substance to try — an indole alkaloid extracted from an African root, then legal in the United States and sold in specialised pharmacies as a stimulant: ibogaine. Lotsof ingests it, hoping for a recreational psychedelic trip. He comes out of it thirty hours later with a discovery that will change his life and launch research still ongoing: the heroin withdrawal syndrome had disappeared. Not eased — disappeared. And the compulsive craving to use did not return in the following weeks.

Lotsof — who was neither a doctor nor a biochemist, but who was methodical — administered ibogaine to six other heroin addicts in his circle. Five out of six reported the same effect: the disappearance of the withdrawal syndrome, the lasting suppression of craving. It is what he would later call the "narcotic addiction interruption" — the interruption of the addictive syndrome. In 1985, he filed US patent 4499096 for this use of ibogaine.

The American medical system very largely ignored this work for thirty years. Ibogaine was classed Schedule I in the United States in 1967 (a substance with no recognised medical value, a high potential for abuse — an absurd classification applied to all the psychedelic molecules of the decade). Lotsof spent the rest of his life trying to impose the clinical recognition of his discovery, creating the Dora Weiner Foundation, then the Global Ibogaine Therapy Alliance. He died in 2010, without having seen ibogaine legalised for therapeutic use in the United States.

Ibogaine clinics — a parallel market

Ibogaine being illegal in the United States and in most European countries, a parallel clinical market developed from the 1990s, in countries where the molecule remains permitted or not specifically regulated: the Bahamas, Mexico (notably the Baja California peninsula), the Netherlands (for occasional courses before a tightening of the regulation), Costa Rica, the Dominican Republic, New Zealand, Brazil.

The cost of a withdrawal course in an ibogaine clinic typically runs between six thousand and fifteen thousand dollars for a five-to-ten-day programme including a cardiac pre-assessment (ECG, electrolytes, liver function), a single administration of a flood dose (twenty to twenty-five milligrams per kilo), continuous cardiac monitoring for thirty-six to forty-eight hours, post-course follow-up and integration.

The published results vary. Brown (Ibogaine in the treatment of substance dependence, Current Drug Abuse Reviews, 2013) reviews several observational studies, sometimes biased by patient selection, sometimes rigorous:

Fifty to seventy per cent of patients remain abstinent one month after a single course (heroin, methadone, cocaine, alcohol).

Thirty to forty per cent remain abstinent at six months.

Twenty to thirty per cent remain abstinent at one year.

These figures, though cautious, are well above the abstinence rates of classic methadone-substitution programmes over the same period. But — and this is crucial — they are measured on populations who have, by definition, the financial means and the strong motivation to commit to a costly and demanding undertaking. The selection bias is considerable.

The honest assessment is this: ibogaine in a single course seems to break the withdrawal syndrome and the acute craving in a way no other known molecule does. But it is not a miracle cure for dependence. Without post-course support (therapy, a support community, a change in living frame), the relapse rate remains high. Ibogaine opens a window. It is what you do with the window that counts.

The ecological threat — industrial extraction

Here is the point that must be named clearly, and that is perhaps the most worrying. To treat a single person in a flood course, about one kilogram of dried root is needed, that is the equivalent of one to two adult plants (five to seven years of growth minimum). If ibogaine became tomorrow a worldwide-recognised therapy and one treated, say, ten thousand people a year (a tiny fraction of the world's heroin addicts), that would represent ten to twenty thousand adult plants a year — extracted from Gabon, Cameroon, the Congo.

At that rate, wild iboga would disappear in less than a decade. It is precisely why CITES listed it in Appendix II in 2022. It is why Gabon drastically controls the export. And it is why certain Bwiti voices — including Guignon, Tatayo, and several Gabonese nima na kombo — ask that Western opioid-withdrawal medicine turn to synthetic noribogaine or to analogues (notably the tabernanthalog developed by David Olson at UC Davis, Nature, 2020), molecules that might perhaps reproduce the anti-addictive effect without requiring wild extraction. It is the only possible ethical path: to remove the root from the medical industry, to leave it its Gabonese ritual function.

VI. What INFUSE says of it

This article has, so far, spoken of the root. A word must now be said, brief, about INFUSE's posture — not as an excuse, not as a central warning, but as ethical transparency.

INFUSE does not sell iboga. INFUSE will never sell iboga. It is not a rhetorical posture. There are three concrete reasons.

First reason — the root is in danger of extinction. Any commercial sale, even ethical, even well-intentioned, mechanically contributes to the pressure on the wild Gabonese resource. As long as there is no certified, large-scale protected-cultivation supply chain that does not plunder the forest — and there is none to date — selling iboga is ecologically untenable.

Second reason — the plant is inseparable from the living Bwiti lineage. To sell the root alone, without the cosmology that holds it, is to extract the molecule while leaving the soul. It is exactly what Yann Guignon names the deadly epistemological error. INFUSE will not take part in that extraction. If a person wishes to meet iboga, there are three paths — and none passes through a shop.

Third reason — the cardiac danger demands a strict medical frame. To sell iboga on an e-commerce site would mean putting into the hands of strangers a molecule capable of killing by blocking the QT interval. No responsible commercial frame allows that.

On the French legal question, for the sake of clarity: since decree no. 2007-1023 of 12 March 2007, ibogaine and all preparations containing it — including the root of Tabernanthe iboga — are listed as narcotics in France. Possession, transfer and use are penalised by article L.5132-7 of the Public Health Code. This factual information is named because it is true, not to frighten. In several European countries (Belgium, Switzerland, the Netherlands, Spain, Italy) the regulation varies; at the time of writing (June 2026), a precise legal consultation is indispensable before any travel or step.

If you want to meet iboga, there are three paths

None is neutral. All ask for a real commitment.

Path 1 — a Bwiti ceremony in Gabon. It is the traditional path, whole, costly in time and respect. One must travel to Gabon (a visa, transport, several weeks minimum), find a recognised nima na kombo, accept a ritual preparation of several days, pay a significant dowry (often a few thousand euros, given in full to the lineage and the temple). Associations such as Blessings of the Forest (Yann Guignon) facilitate these steps while guaranteeing the ethical remuneration of the Gabonese communities. This path is the only one where the cosmology is held. It is also the only one where the initiation takes place in its context; that is what changes everything.

Path 2 — a medicalised ibogaine clinic, for those who seek an opioid withdrawal and who cannot travel to Gabon. The serious clinics (the list changes; the Global Ibogaine Therapy Alliance keeps a register of ethically certified clinics) follow a standardised protocol: a prior cardiac assessment, continuous monitoring, post-course support. It is not a ritual meeting with the plant — it is a therapeutic intervention on the addiction. The distinction is clear and must be held.

Path 3 — reading, listening, the indirect meeting. It is the path INFUSE recommends for the great majority of people interested in iboga. Read Fernandez (Bwiti, Princeton), read Bekale (L'Iboga et le Bwiti), watch the serious documentaries (notably Ibogaine: Rite of Passage by Ben Deloenen, 2004; I'm Dangerous With Love by Michel Negroponte on Lotsof, 2009), listen to the contemporary Bwiti voices (Tatayo, Yann Guignon, several Gabonese nima na kombo accessible via their sites). This path does not give the vision — but it gives the right posture. And it is, for most of us, the most respectful offering.

"We are not against Westerners coming to meet iboga. We are against Westerners coming to take iboga and leave nothing. Bring your gratitude, bring your work, bring your money to the temple. Take a memory. Leave the rest." — Tatayo (Atome Ribenga), nima na kombo Bwiti Fang, interview Le Monde, 2018 — INFUSE reading — Tatayo, a Frenchman initiated into the Bwiti for more than thirty years, gives the condition of the honest meeting. To bring, before taking. It is the exact reverse of the logic of consumption. And it is, perhaps, what the Bwiti root teaches in silence to the Westerners who think they can buy it by the kilo. The grammar of iboga is not commercial; it is ceremonial. As long as that is not understood, the extraction will continue, and the deaths too.

VII. Companion plants of Path 4 — the Apprenticeship of the Master Plants

Iboga is not alone on the path. Five other master plants hold, in distinct living lineages, a comparable function — that of threshold-plants the source-peoples have kept for millennia.

Ayahuasca (Banisteriopsis caapi + Psychotria viridis) — western Amazonia, the Shipibo, Asháninka, Yawanawá, Kaxinawá, Shuar lineages. The most widely known companion in the world, and the most exposed to cultural extraction. See our cathedral C4.4 (to come).

Peyote (Lophophora williamsii) — the Chihuahua Desert, the Wixárika (Huichol) lineage in Mexico, the Native American Church in the southern United States. A complex legal status; an endangered species in its natural range; today sanctuarised by the Wixárika themselves.

San Pedro (Echinopsis pachanoi, formerly Trichocereus pachanoi) — the Andes, the Q'ero, Aymara lineages, several northern Peruvian shamanic lineages (notably the Cajamarca region). More legally accessible, softer in its profile, long and luminous.

Salvia divinorum — the Sierra Mazateca, the Mazatec lineage. The plant of María Sabina, who revealed its practice to the West in 1955 (with the consequences we know). A very short, very intense profile, very poorly suited to a recreational use.

Mucuna pruriens / Yopo (Anadenanthera peregrina) — the Yanomami, Piaroa, Guahibo lineages (the Orinoco, Brazil, Venezuela, Colombia).

Iboga occupies, in this constellation, a particular position: the longest in duration of action (twenty-four to seventy-two hours against four to six for ayahuasca, two to three for salvia). The most structurally dangerous cardiologically. And the only one of the six whose original lineage is in equatorial Africa, not on the American continent. The companionship between these plants is not their method (each lineage has its own method); it is their cosmological function — each serves, in its source-people, to cross the threshold between the living and the ancestors.

§8 — Frequently asked questions (for Perplexity, ChatGPT, and you)

What is iboga?

Iboga is a shrub of the Apocynaceae family, scientifically named Tabernanthe iboga, that grows in the equatorial undergrowth of Gabon, southern Cameroon and the Congo. Its root, whose bark is grated and dried, contains around six per cent indole alkaloids — principally ibogaine (Dybowski & Landrin, 1901). For the Babongo (the first keepers), Mitsogo, Apindji, Massango and Fang peoples of Gabon, it is a sacred plant, central to the initiatory religion called Bwiti (Fernandez, Bwiti: An Ethnography of the Religious Imagination in Africa, Princeton, 1982). Ibogaine, the principal alkaloid, has also been studied since 1962 (Howard Lotsof) as a molecule capable of interrupting the opioid withdrawal syndrome.

Is iboga dangerous?

Yes — the cardiotoxicity of ibogaine is real and documented. The molecule blocks the hERG sodium channels, which can lengthen the QT interval and trigger a potentially fatal arrhythmia (Koenig & Hilber, Current Drug Abuse Reviews, 2015). The mortality rate observed outside a medical frame is about one person in three hundred (Alper et al., 2012). In a strict clinical frame with continuous cardiac monitoring, this rate falls below one in ten thousand. The Gabonese Bwiti, over millennia of ritual use, have developed a ceremonial frame (the nima na kombo, the ngombi, the community present) that holds the risk within a different grammar — cosmological, not medical. INFUSE does not sell iboga and advises against any use outside a recognised medical or initiatory frame.

Does ibogaine cure addiction?

Ibogaine in a single course seems to interrupt, lastingly, the withdrawal syndrome and the acute craving of opioids, cocaine, sometimes alcohol (Brown, Current Drug Abuse Reviews, 2013). The observational studies report fifty to seventy per cent abstinence at one month, twenty to thirty per cent at one year — figures above classic methadone substitution. But to interrupt is not to cure. Without post-course support (therapy, community, a change in living frame), the relapse rate remains high. Ibogaine opens a window; what one does with the window counts. More broadly, the word cure itself is imprecise here: addiction is a multi-causal phenomenon, and no molecule alone is enough.

Where to find a legal iboga ceremony?

The most whole path is to go to Gabon, into a recognised Bwiti lineage. Several structures facilitate this step for non-Gabonese — notably the Blessings of the Forest association founded by Yann Guignon, which guarantees the ethical remuneration of the Gabonese communities and the authenticity of the lineage. Count on several weeks of stay, a dowry of a few thousand euros given to the temple, a ritual preparation of several days. For a therapeutic use (opioid withdrawal), ethically certified ibogaine clinics exist in Mexico, the Bahamas, New Zealand, Costa Rica — the Global Ibogaine Therapy Alliance keeps a register. In France, ibogaine has been classed as a narcotic since the decree of 12 March 2007.

Is the Bwiti a religion?

Yes, in the full sense. The Bwiti is a living, structured Gabonese initiatory religion, with its temples (mbandja), its priests (nima na kombo), its songs, its sacred instrument (the ngombi, an eight-stringed harp), its cosmology (the meeting with the ancestors, the multicoloured road, the cosmic tree often identified with iboga itself). Recognised as a religion by the Gabonese state, the Bwiti has today several hundred thousand faithful. Two great branches coexist: the Mitsogo Bwiti (or Disumba), closer to the pre-colonial forms, and the Fang Bwiti (or Mwiri), syncretic, integrating Christian elements since the start of the 20th century. See Fernandez (Princeton, 1982) for the English-language anthropological reference and Bekale for the French-language one.

How much does an ibogaine treatment cost?

In a serious clinic (Mexico, the Bahamas, Costa Rica), an ibogaine withdrawal course runs between six thousand and fifteen thousand US dollars for a five-to-ten-day programme including a pre-course cardiac assessment (ECG, electrolytes, liver function), the administration of a flood dose (twenty to twenty-five milligrams per kilo), continuous cardiac monitoring for thirty-six to forty-eight hours post-administration, and a few days of integration support. A traditional Bwiti initiation in Gabon generally costs less in direct fees (the dowry to the temple varies by lineage, often between two thousand and five thousand euros) but asks for a significant investment of time (travel, a stay of several weeks, ritual preparation). The two paths are not comparable — they are different undertakings for different intentions.

Why does INFUSE not sell iboga?

For three reasons. One — the plant is in danger of extinction (CITES Appendix II since 2022, a five-to-seven-year plant before ceremonial maturity, exponential world demand). Any commercial sale, even ethical, weighs on the wild Gabonese resource. Two — iboga is inseparable from the living Bwiti lineage; separating the molecule from its cosmology leads to the cardiac deaths and psychic decompensations observed in the courses outside the lineage. Three — the cardiotoxicity demands a strict medical frame incompatible with a retail trade. INFUSE honours this plant by speaking of it with precision, by pointing towards the Gabonese Bwiti, by refusing the trade.

Iboga vs ayahuasca — what is the difference?

Five major differences. Origin: iboga comes from Gabon (the Bwiti, Babongo, Mitsogo, Fang lineage); ayahuasca comes from western Amazonia (the Shipibo, Asháninka, Yawanawá, Kaxinawá lineages, several others). Botany: iboga = a single plant (Tabernanthe iboga); ayahuasca = a combination of two plants (Banisteriopsis caapi + Psychotria viridis). Chemistry: iboga = ibogane-type indole alkaloids (ibogaine, noribogaine); ayahuasca = DMT + beta-carboline MAOI harmines. Duration: iboga = twenty-four to seventy-two hours; ayahuasca = four to six hours. Experiential profile: iboga confronts with ancestral memory (Pendell), often eyes closed, stillness, a voyage through one's own life; ayahuasca operates through visual narrative and purging, often more dynamic, more a dialogue with plant-spirits. Both are master plants; neither replaces the other.

§10 — Sources (transparency)

INFUSE Forest sources (Tier 1 and Tier 2 consulted in this session)

Richard Evans Schultes & Albert Hofmann, Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers, Healing Arts Press, 1992 (revised edition). The canonical ethnobotanical reference on Iboga, the Bwiti and the bambzie/banzie; the Tabernanthe chapter "Guide to the Ancestors," pp. 112–115. INFUSE Tier 1 + Tier 2 digest consulted.

Christian Rätsch, The Encyclopedia of Psychoactive Plants: Ethnopharmacology and Its Applications, Park Street Press, 2005 (the Tabernanthe iboga entry). A pharmacognosy reference + the Dose-Set-Setting framework + the concept of plant teachers. INFUSE Tier 1 + Tier 2 digest consulted.

Christian Rätsch, The Encyclopedia of Aphrodisiacs, Park Street Press, 2013 (the mention of iboga as a traditional Bwiti aphrodisiac). A secondary source.

Dale Pendell, Pharmako/Gnosis: Plant Teachers and the Poison Path, Mercury House 2005 / North Atlantic Books 2010. The section on iboga in the Daimonica category ("here-there-be-dragons"). The conceptual frame of "ground state training" and of the phenomenological "signature" of the visionary plants. INFUSE Tier 1 digest consulted.

Main academic sources

James W. Fernandez, Bwiti: An Ethnography of the Religious Imagination in Africa, Princeton University Press, 1982. The reference work in English on the Fang Bwiti, the fruit of twenty years of fieldwork in Gabon. The Mitsogo / Fang distinction, the initiatory structure, the role of the nima na kombo and the ngombi.

Daniel Bekale, L'Iboga et le Bwiti, to be digested in the INFUSE Forest Phase 1 (before the S8 cathedral). The French-language reference on the Mbiri ceremonial dimension, the Disumba initiation, the relation to the world of the ancestors.

Kenneth R. Alper, Howard S. Lotsof et al., Treatment of acute opioid withdrawal with ibogaine, The American Journal on Addictions 8(3), 1999. The founding clinical publication on the medical use of ibogaine for opioid withdrawal.

Kenneth R. Alper et al., Treatment-related mortality of ibogaine therapy: a review of fatalities, Journal of Forensic Sciences, 2012. A review of the deaths linked to ibogaine outside and within a clinical frame, an estimate of the mortality rate.

Deborah C. Mash et al., Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures, Annals of the New York Academy of Sciences, 2000. The pharmacokinetic mapping of ibogaine and noribogaine.

Paul Glue et al., Ibogaine and noribogaine: pharmacokinetics and effects on opioid withdrawal, British Journal of Clinical Pharmacology 80(5), 2015. A detailed pharmacokinetic study in human subjects.

Geoffrey Brown, Ibogaine in the treatment of substance dependence, Current Drug Abuse Reviews 6(1), 2013. A meta-review of the observational studies, the abstinence rates at 1 month / 6 months / 1 year.

Xaver Koenig & Karlheinz Hilber, The anti-addiction drug ibogaine and the heart: a delicate relation, Current Drug Abuse Reviews 8(2), 2015. The molecular mechanism of the cardiotoxicity (hERG blockade, QT lengthening).

Howard S. Lotsof, Rapid method for interrupting the narcotic addiction syndrome, US patent 4499096, 1985. The historical founding act of the anti-addictive use of ibogaine.

Dybowski & Landrin, Sur l'iboga, sur ses propriétés excitantes, sa composition et sur l'alcaloïde nouveau qu'il renferme, Comptes Rendus de l'Académie des Sciences, 133, 1901. The historical discovery of ibogaine.

Lindsay P. Cameron, David E. Olson et al., A non-hallucinogenic psychedelic analogue with therapeutic potential (on tabernanthalog), Nature 589, 2021. The development of synthetic analogues for the potential substitution of the wild root.

Legal sources

Decree no. 2007-1023 of 12 March 2007 amending the order of 22 February 1990 setting the list of substances classed as narcotics — France. The listing of ibogaine and derived preparations.

CITES — Convention on International Trade in Endangered Species, Tabernanthe iboga in Appendix II since 2022. The international frame for the protection of the wild species.

Gabonese Republic — Law 22/94 on the protection of the national cultural heritage, the 2000 classification of iboga.

Documentaries and contemporary sources

Ben Deloenen, Ibogaine: Rite of Passage, documentary, 2004. Follows several clinical courses and a Bwiti initiation.

Michel Negroponte, I'm Dangerous With Love, documentary, 2009. On Howard Lotsof and his work.

Yann Guignon (Blessings of the Forest), talks and interviews 2010–2024 on the safeguarding of the Bwiti and iboga. A contemporary ethical voice on the question of extraction.

Tatayo (Atome Ribenga), interviews in Le Monde (2018) and Vice (2019). A nima na kombo of the Fang Bwiti, France/Gabon.

Global Ibogaine Therapy Alliance (GITA), a register of clinics and ethical protocols. An international reference resource for therapeutic courses.

— Iboga is not sold, not bought, not prescribed alone. It is met — when one is ready to bring before taking. — INFUSE editorial line

Article published — 2026-06-02. Pillar, Path 4 — The Apprenticeship of the Master Plants. Phase 1 of the Living School Production Plan V2. INFUSE voice 65/20/15 (clarity/animist poetry/ethical edge); five-layer disenchantment filter applied; the INFUSE-VERITE-PRESENTE + INTEGRITE-VERITE + LANGAGE-FILTRE triptych respected. Sources: 14. Named source-peoples: Babongo (Bongo), Mitsogo (Tsogo), Apindji, Massango, Nkomi, Fang, Punu. Iboga anti-pattern of 2026-05-22 banned: an article centred on the root and the Bwiti lineage, "INFUSE does not sell" kept to §VI as ethical transparency, never as a hook or a central subject.